S. Whitfield
Claim 50392847156 · 76 F · 4-day LOS · POS 21 · billed charge $38,900
📄 Claim as submitted
Billed DRG
871
Sepsis w/o MV >96h — WITH MCC
Pays
$13,598
A41.9Sepsis, unspecified organismPDX
N17.9Acute kidney injury, unspecifiedMCC
J18.9Pneumonia, unspecified organismCC
RW 1.9425 × $7,000 base · FY2026 V43.0
🩺 Medical chart
Ridgeview Memorial Hospital
Inpatient Progress Note — Hospital Medicine
er aes el a Ee ee
patient: S. Whitfield MRN: 74102-C9 DOB: --/--/1949 (76 yo F)
Admit date: Day 1 POS: 21 - Inpatient Attending: T. Nakashima, MD
History of present illness:
76-year-old female with history of CKD stage 3 (documented baseline creatinine ‘around
1.5 per outpatient chart, not confirmed this admission") and prior aspiration events,
brought from assisted living facility for lethargy, decreased oral intake, and low-grade
fever over 2 days.
Vitals and initial labs:
Temp 38.1C, HR 98, BP 104/62, RR 20, SpO2 91% on room air. WBC 14.6, creatinine 2.0
mg/dL (no prior value in this record for comparison). Lactate 1.7 mmol/L. Chest x-ray
showed right lower lobe opacity. Urinalysis with moderate bacteria, few WBC.
Assessment on admission:
Admitting note states ‘concern for sepsis, favor pneumonia as source, possible urinary
contribution cannot be excluded.’ No explicit statement identifying which source is
being treated as the principal problem.
Hospital course:
Started on empiric ceftriaxone and azithromycin for presumed community-acquired
pneumonia. No vasopressors required at any point; blood pressure remained stable
throughout admission. No repeat creatinine obtained after hospital day 1, so trend
during treatment is not documented in this record. Blood cultures resulted no growth at
48 hours. Oxygen requirement improved from 3L NC to room air by day 3.
Assessment and plan:
Community-acquired pneumonia versus urosepsis, clinically improved. Acute kidney injury
versus chronic baseline, not distinguished in this admission due to absence of repeat
labs. Discharged hospital day 4 on oral antibiotics; recommend nephrology follow-up for
renal function reassessment as outpatient.
🤖 Agent analysis
💬 Follow-up questions
Ask any question about this analysis — coding logic, guideline rationale, documentation gaps, or what-if scenarios.
Rate basis (FY2026 / V43.0): DRG 871 RW 1.9425 (verified CMS); DRG 872 RW 1.0299 (verified CMS FY2024); base $7,000 blended IPPS rate. Validation logic grounded in ICD-10-CM Official Guidelines §I.C.1.d, AHA Coding Clinic, UHDDS, and Sepsis-3 (Singer et al., JAMA 2016). This tool surfaces a recommendation for a human auditor and does not auto-adjudicate.